Search results
Results from the WOW.Com Content Network
Abuse of the drug or other substances may lead to severe psychological or physical dependence. The complete list of Schedule II substances is as follows. The Administrative Controlled Substances Code Number and Federal Register citation for each substance is included.
What links here; Related changes; Upload file; Special pages; Permanent link; Page information; Cite this page; Get shortened URL; Download QR code
Schedule 8 (S8) drugs and poisons, otherwise known as Controlled Drugs, are schedule 9 prohibited substances that are appropriate preparations for therapeutic use which have high potential for abuse and addiction. The possession of these medications without authority is the same as carrying a prohibited substance and is illegal.
Rank Drug Trade name Type Main indications Company Sales (USD millions/year) ∆ vs 2014 1 Adalimumab: Humira Biologic Rheumatoid arthritis: AbbVie Inc. 14,012 1,469
Schedule 2 may refer to: Second Schedule of the Constitution of India, about the rights of government officials; Schedule II Controlled Substances within the US Controlled Substances Act List of Schedule II drugs (US) Schedule II Controlled Drugs and Substances within the Canadian Controlled Drugs and Substances Act
Under retail and distribution: [citation needed] Schedule X drugs - narcotics; Schedule H and L - injectables, antibiotics, antibacterials; Schedule C and C1 - biological products, for example serums and vaccines; Under manufacturing practice: Schedule N - list of the equipment for the efficient running of manufacturing wing, qualified ...
It also maintains List I of chemicals and List II of chemicals, which contain chemicals that are used to manufacture the controlled substances/illicit drugs. The list is designated within the Controlled Substances Act [ 1 ] but can be modified by the U.S. Attorney General as illegal manufacturing practices change.
The Comprehensive Drug Abuse Prevention and Control Act of 1970, Pub. L. 91–513, 84 Stat. 1236, enacted October 27, 1970, is a United States federal law that, with subsequent modifications, requires the pharmaceutical industry to maintain physical security and strict record keeping for certain types of drugs. [1]